SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CME GROUP INC. (CME) (CIK 0001156375) (CME) — Mar 31, 2011

CME GROUP INC. (CME) (CIK 0001156375)
Date: March 31, 2011 · CIK: 0001156375 · Accession: 0000000000-11-019852

Financial Reporting Internal Controls Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
March 31, 2011
Author
Daniel L. Gordon
Form
UPLOAD
Company
CME GROUP INC. (CME) (CIK 0001156375)

Letter

Re: CME Group Inc. Form 10- K Filed February 28, 2011 File No. 001 -31553 Dear Mr. Parisi : We have reviewed your filing and have t he following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter within ten business days by amending your filing, by providing the requested informat ion, or by advising us when you will provide the requested response. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendm ent to your filing and the information you provide in response to these comments, we may have additional comments.

March 31, 2011

Mr. James E. Parisi Chief Financial Officer CME Group Inc. 20 South Wacker Drive Chicago, IL 60606

Note 6. Performance Bonds and Guaranty Fund Contributions, page 81 1. In future filings please expand your disclosure to address why certain performance bonds, guaranty fund contributions, cross -margin arrangements and performance collateral for delivery have been included on your balance sheet, while other performance bonds and performance collateral for delivery, non -cash deposits and IEF funds have not been included. Please provide us with your proposed disclosure, addressing whether 1) you have risks and rewards associated with ownership of the collateral, 2) the funds are held by you, 3) the funds are available for your use and 4) if you receive interest income from the deposits.

Note 8. Intangible Assets and Goodwill, page 84

2. In future filings please expand your disclosure to describe the nature of indefinite -lived trading products. Please provide us with your proposed futur e disclosures.

Mr. James E. Parisi CME Group Inc. March 31, 2011 Page 2

Note 18. Contingencies, page 96 3. We note that you are involved in various legal proceedings. If there is at least a reasonable possibility that a loss may be incurred as a result of these proceedings, please disclose an estimate or range o f possible loss or include a statement that such an estimate cannot be made. Refer to ASC 450- 20-50-4. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the inform ation the Securities Exchange Act of 1934 and all applicable Exchange Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are r esponsible for the accuracy and adequacy of the disc losures they have made.

In responding to our comments, please provide a written statement from the company acknowledging that:

• the company is responsible for the adequacy and accuracy of the disclosure in the filing;

• staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

• the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federa l securities laws of the United States.

You may contact Kristi Marrone at (202) 551- 3429 or me at (202) 551 -3486 if you have questions regarding comments on the financial statements and related matters.

Sincerely,
Daniel L. Gordon
Branch Chief

Show Raw Text
March 31, 2011

Mr. James E. Parisi
Chief Financial Officer
CME Group Inc.
20 South Wacker Drive
Chicago, IL  60606

Re: CME Group Inc.
 Form 10- K
Filed February 28, 2011
File No. 001 -31553
 Dear Mr. Parisi :
 We have reviewed your filing and have t he following comments.  In some of our
comments, we may ask you to provide us with information so we may better understand your disclosure.
 Please respond to this letter within ten business days by amending your filing, by
providing the requested informat ion, or by advising us when you will provide the requested
response.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
 After reviewing any amendm ent to your filing and the information you provide in
response to these comments, we may have  additional comments.

Note 6. Performance Bonds and Guaranty Fund Contributions, page 81
 1. In future filings please expand your disclosure to address why certain performance bonds, guaranty fund contributions, cross -margin arrangements and performance collateral for
delivery have been included on your balance sheet, while other performance bonds and performance collateral for delivery, non -cash deposits  and IEF funds have not been
included.  Please provide us with your proposed disclosure, addressing whether 1) you have risks and rewards associated with ownership of the collateral, 2) the funds are held by you, 3) the funds are available for your use and 4) if you receive interest income from
the deposits.

Note 8. Intangible Assets and Goodwill, page 84

2. In future filings please expand your disclosure to describe the nature of indefinite -lived
trading products.  Please provide us with your proposed futur e disclosures.

Mr. James E. Parisi
CME Group Inc.
March 31, 2011
Page 2

Note 18. Contingencies, page 96
 3. We note that you are involved in various legal proceedings.  If there is at least a reasonable possibility that a loss may be incurred as a result of these proceedings, please disclose an estimate or range o f possible loss or include a statement that such an estimate
cannot be made.  Refer to ASC 450- 20-50-4.
 We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the  inform ation the Securities Exchange Act of
1934 and all applicable Exchange Act rules require.  Since the company and its management are in possession of all facts relating to a company’s disclosure, they are r esponsible for the accuracy
and adequacy of the disc losures they have made.

 In responding to our comments, please provide  a written statement from the company
acknowledging that:

• the company is responsible for the adequacy and accuracy of the disclosure in the filing;

• staff comments or changes to disclosure in response to staff comments do not foreclose
the Commission from taking any action with respect to the filing; and

• the company may not assert staff comments as a defense in any proceeding initiated by
the Commission or any person under the federa l securities laws of the United States.

You may contact Kristi Marrone  at (202) 551- 3429 or me at (202) 551 -3486 if you have
questions regarding comments on the financial statements and related matters.

Sincerely,

Daniel L. Gordon
Branch Chief